**Executive Summary**
This document reports on a new multi-functional nanoplatform therapy for Alzheimer's Disease (AD) developed by researchers at the Institute of Nano Science and Technology (INST), Mohali. The therapy, integrating an antioxidant from green tea, a neurotransmitter, and an amino acid into nanoparticles, targets multiple pathological hallmarks of AD simultaneously. The research, published in the journal "Small", demonstrates promising results in lab experiments and mouse models, showing potential for improved treatments and personalized care for Alzheimer's disease.
**Key Points / Main Content**
* **New Alzheimer's Therapy:** Researchers have developed a nanoplatform therapy that integrates a polyphenol with antioxidant properties found in green tea, neurotransmitter, and amino acid. This approach aims to change the path of the progression of AD, slowing it, improving memory, and supporting thinking skills.
* **Multifunctional Nanoplatform:** The therapy uses EGCG-dopamine-tryptophan nanoparticles (EDTNPs) to simultaneously target amyloid aggregation, oxidative stress, inflammation, and neuronal degeneration.
* **Enhanced Neuroprotection:** The therapy incorporates Brain-Derived Neurotrophic Factor (BDNF) onto EDTNPs (B-EDTNPs) to both clear neurotoxic Amyloid Beta aggregates and enhance neuronal regeneration.
* **Synthesis and Techniques:** The synthesis of EDTNPs involves biocompatible assembly techniques such as pressure assisted hydrothermal and electrostatic based co-incubation methods.
* **Experimental Results:** In lab experiments and mouse models, the nanoparticles disassembled toxic plaques, reduced inflammation, restored balance inside brain cells, and improved memory and learning.
* **Publication:** The research is published in the journal "Small".
**Impact Analysis**
**Alzheimer's Patients**
* **Impact:** Potential for improved treatment options that target multiple aspects of the disease.
* **Action Required:** None specified in the document.
**Caregivers**
* **Impact:** Potential for easing the burden of care through more effective treatments.
* **Action Required:** None specified in the document.
**Researchers and Medical Professionals**
* **Impact:** Provides a new avenue for Alzheimer's research and treatment development.
* **Action Required:** Further investigation and clinical trials to validate the effectiveness of the therapy.
Key Entities Referenced
Alzheimer's Disease (AD): The disease targeted by the new therapy.
Department of Science and Technology (DST): The department under which the research institute operates.
Institute of Nano Science and Technology (INST), Mohali: The research institute where the Alzheimer's therapy was developed.
Ministry of Science & Technology: The ministry overseeing the research and the press release.
Ministry of Science & Technology
New path found for a better & comprehensive
therapy for Alzheimer ’s disease
प्रव तथ: 16 DEC 2025 11:50AM by PIB Delhi
A new path involving nanoparticles integrating a polyphenol with antioxidant properties found in green
tea, neurotransmitter, and amino acid has the potential to treat Alzheimer’s Disease (AD) by changing the
path of the progression of the disease, slowing it, improving memory, and supporting thinking skills.
Alzheimer's disease is a growing global health concern. As the population ages, the disease poses
significant challenges in terms of patient care, economic burden underlining the need for effective
treatments and preventive strategies.
Conventional Alzheimer’s therapies often target only a single pathological feature such as amyloid
aggregation or oxidative stress, yielding limited clinical benefit. However, AD which is a multifactorial
disease and hence needed a multifunctional nanoplatform capable of addressing multiple disease
mechanisms simultaneously.
Researchers at Institute of Nano Science and Technology (INST), Mohali, an autonomous institute of the
Department of Science and Technology (DST), integrated nanotechnology, molecular biology, and
computational modelling to develop a multifunctional therapy for Alzheimer’s Disease.
The therapy integrates epigallocatechin-3-gallate (EGCG) an antioxidant found in green tea, dopamine, a
neurotransmitter important for mood and tryptophan, an amino acid involved in many cellular functions
into a nanoparticle called EGCG-dopamine-tryptophan nanoparticles (EDTNPs). This enables it to
simultaneously targets amyloid aggregation, oxidative stress, inflammation, and neuronal degeneration,
four key pathological hallmarks of AD.
Fig 1 Illustrating the synthesis of NPs and their multifunctional role in combating AD.Incorporation of Brain-Derived Neurotrophic Factor (BDNF), a protein crucial for the survival, growth,
and function of neurons onto EDTNPs (B-EDTNPs) creates a dual-action nanoplatform that not only
clears neurotoxic Amyloid Beta aggregates (protein clumps that disrupt neural function and drive
Alzheimer’s disease pathology) but also enhances neuronal regeneration. This is a rare approach in
Alzheimer’s therapeutics which uniquely combines antioxidant, anti-amyloid, and neurotrophic actions for
the therapy.
The research work carried out by Dr. Jiban Jyoti Panda and team (Himanshu Shekhar Panda & Sumit)
from INST, Mohali, with support from Dr. Ashok Kumar Datusalia (NIPER Raebareli) and Dr Nisha
Singh (Gujrat Biotechnology University), involves the synthesis of EDTNPs using biocompatible
assembly techniques like pressure assisted hydrothermal and electrostatic based co-incubation methods to
combine antioxidant, neurotransmitter, and amino acid components. These nanoparticles were then
functionalized with BDNF, producing B-EDTNPs with enhanced neuroprotective potential.
Fig.2. Illustrating the feasible mechanism of action of NPs [TrkB (Tropomyosin receptor kinase B); PI3K
(Phosphoinositide 3-kinase); MAPK (Mitogen-activated protein kinase); PLCγ (Phospholipase C-
gamma); PP (pyrophosphate)].
In lab experiments and mouse models, these nanoparticles disassembled toxic plaques, reduced
inflammation, restored balance inside brain cells, and even improved memory and learning. Computer
simulations further confirmed that the nanoparticles latch onto harmful Aβ fibrils and pull them apart at
the molecular level.
This research, published in the Journal, “Small”, could help people with Alzheimer’s disease by offering a
treatment that works on multiple levels. The nanoparticles not only remove harmful protein plaques but
also reduce brain stress, inflammation and help nerve cells grow through BDNF. In the long run, the
therapy could make life better for patients, ease the burden on caregivers, and lead to more effective and
personalized treatments for Alzheimer’s disease.
Publication link: https://doi.org/10.1002/smll.202411701
****
NKR/AK
(रलीज़ आईडी: 2204447) आगंतुक पटल : 1143
इस वज्ञ को इन भाषाओ ंम पढ़: Urdu , ही